Effects of Glucose and Lipid Metabolism and Visceral Fat in Overweight and Obese Patients with Type 2 Diabetes Mellitus Treated with Dulaglutide Combined with Dapagliflozin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of Glucose and Lipid Metabolism and Visceral Fat in Overweight and Obese Patients with Type 2 Diabetes Mellitus Treated with Dulaglutide Combined with Dapagliflozin

Published:2024 Issue:05 Volume:14 Page:2258-2264
ISSN:2161-8712
Container-title:Advances in Clinical Medicine
language:
Short-container-title:ACM

Author:

杨云阁

Publisher

Hans Publishers

Reference19 articles.

1. 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年) [J]. 中华糖尿病杂志, 2020, 13(4): 315-409.

2. 张强, 石新芳, 袁向珍. 中国成人肥胖、中心性肥胖与高血压和糖尿病的相关性研究[J]. 临床医药文献电子杂志, 2017, 4(45): 8749-8752.

3. Efficacy and safety of dapagliflozin and liraglutide in patients with type 2 diabetes mellitus and newly diagnosed as overweight/obese

4. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

5. The Impact of Obesity on Cardiovascular Disease Risk Factors and Subclinical Vascular Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP